<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47028073Tirofiban hydrochloride monohydrate 150915-40-5

    Tirofiban hydrochloride monohydrate 150915-40-5

    簡要描述:Tirofiban hydrochloride monohydrate 150915-40-5
    Tirofiban hydrochloride monohydrate is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonist

    • 產(chǎn)品型號:abs47028073
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時間:2026-01-15
    • 訪  問  量:632

    詳細(xì)介紹

    品牌absinCAS150915-40-5
    分子式C22H39ClN2O6S純度>98%
    分子量495.07貨號abs47028073
    規(guī)格5mg供貨周期現(xiàn)貨
    主要用途is a potent non-peptide應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    Tirofiban hydrochloride monohydrate 150915-40-5

    產(chǎn)品描述
    描述

    Tirofiban hydrochloride monohydrate is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonist

    純度
    >98%
    儲存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    別名
    鹽suan替羅非班水合物
    外觀
    白色至類白色粉末
    可溶性/溶解性
    DMSO : 12 mg/mL (24.24 mM; Need ultrasonic and warming)
    生物活性
    靶點
    GPIIb/IIIa
    In vitro(體外研究)
    Tirofiban (MK-383, Aggrastat) is a nonpeptide derivative of tyrosine that selectively inhibits the GP-IIb/IIIa receptor, with minimal effects on the ɑvβ3 vitronectin receptor. It inhibits platelet aggregation of gel-filtered platelets induced by 10 μM ADP with IC50 of 9 nM, but the IC50 for inhibition of human umbilical vein adhesion to vitronectin, which depends on ɑvβ3 vitronectin receptors, is 62 μmol/L.
    In vivo(體內(nèi)研究)
    Tirofiban Hydrochloride (10 to 500 mg/kg or 360-min continuous i.v. infusions of 1 to 10 micrograms/kg/min) inhibits platelet aggregation responses to ADP and collagen in canine models. When administered to humans at 0.15μg/kg/min for 4 h, Tirofiban produced a 2.5-fold increase in bleeding time and 97% inhibition of ADP-induced platelet aggregation.
    參考文獻(xiàn)
    參考文獻(xiàn)
    • 1. Winter JP, Juergens CP. Cardiovasc Hematol Disord Drug Targets. 2008 Jun;8(2):138-46.

    • 2. van 't Hof AW, Valgimigli M. Drugs. 2009;69(1):85-100.

    研究領(lǐng)域
    研究領(lǐng)域
    Signal TransductionCytoskeleton / ECMCytoskeleton
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    Tirofiban hydrochloride monohydrate 150915-40-5溫馨提示:本產(chǎn)品僅作科研實驗使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補充說明:

    • 驗證碼:

      請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號了解更多信息:
    歡迎您關(guān)注我們的微信公眾號
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    少妇日韩 | 天堂网www在线资源网 | 四虎av| 秋霞日韩在线 | av字幕网站 |